drugset / Trial / NCT07538674

Peiyuan Guben Tongluo Ointment for Elderly Sarcopenia

NCT07538674 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

With the agarose concentrating group of Peiyuan Guben Tongluo Ointment set as the parallel control and an external control established simultaneously, this study aimed to evaluate the increases from baseline in DXA-measured limb muscle mass after 12 weeks of medication in elderly sarcopenia patients treated with the Ejiao concentrating group of Peiyuan Guben Tongluo Ointment.

Timeline

Start
2026-04
Primary completion
2027-03-31
Completion
2028-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Peiyuan Guben Tongluo Ointment (Ejiao concentrated) Traditional medicine (herbal / TCM) 20 g —

Indications